Natalia Onishchenko

Dr. Natalia Onishchenko

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
NONatalia Onishchenko
Natalia Onishchenko
DTDaria Tretiakova
Daria Tretiakova
EVElena Vodovozova
Elena Vodovozova

1 June 2018 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
DTDaria Tretiakova
Daria Tretiakova
NONatalia Onishchenko
Natalia Onishchenko
IBIvan Boldyrev
Ivan Boldyrev
IMIlya Mikhalyov
Ilya Mikhalyov
ATAlexander Tuzikov
Alexander Tuzikov
EVElena L. Vodovozova
Elena L. Vodovozova

28 February 2019 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
ESEkaterina S. Shchegravina
Ekaterina S. Shchegravina
DTDaria Tretiakova
Daria Tretiakova
AAAnna Alekseeva
Anna Alekseeva
TGTimur R. Galimzyanov
Timur R. Galimzyanov
YUYuri N. Utkin
Yuri N. Utkin
IBIvan Boldyrev
Ivan Boldyrev

1 May 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
AAAnna Alekseeva
Anna Alekseeva
EMEkaterina V Moiseeva
Ekaterina V Moiseeva
NONatalia Onishchenko
Natalia Onishchenko
IBIvan Boldyrev
Ivan Boldyrev
ASAlexander S Singin
Alexander S Singin
EVElena L. Vodovozova
Elena L. Vodovozova
In a previous study, a formulation of methotrexate (MTX) incorporated in the lipid bilayer of 100-nm liposomes in the form of diglyceride ester (MTX-DG, lipophilic prodrug) was developed. In this study, first, the interactions of MTX-DG liposomes with various human and mouse tumor cell lines were studied using fluorescence techniques. The liposomes composed of egg phosphatidylcholine (PC)/yeast phosphatidylinositol/MTX-DG, 8:1:1 by mol, were labeled with fluorescent analogs of PC and MTX-DG. Carcinoma cells accumulated 5 times more MTX-DG liposomes than the empty liposomes. Studies on inhibitors of liposome uptake and processing by cells demonstrated that the formulation used multiple mechanisms to deliver the prodrug inside the cell. According to the data from the present study, undamaged liposomes fuse with the cell membrane only 1.5–2 hours after binding to the cell surface, and then, the components of liposomal bilayer enter the cell separately. The study on the time course of plasma concentration in mice showed that the area under the curve of MTX generated upon intravenous injection of MTX-DG liposomes exceeded that of intact MTX 2.5-fold. These data suggested the advantage of using liposomal formulation to treat systemic manifestation of hematological malignancies. Indeed, the administration of MTX-DG liposomes to recipient mice bearing T-cell leukemic lymphoma using a dose-sparing regimen resulted in lower toxicity and retarded lymphoma growth rate as compared with MTX.

1 April 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DTDaria Tretiakova
Daria Tretiakova
Irina M. Le-DeygenIrina M. Le-Deygen
Irina M. Le-Deygen
NONatalia Onishchenko
Natalia Onishchenko
JKJudith Kuntsche
Judith Kuntsche
Elena V. KudryashovaElena V. Kudryashova
Elena V. Kudryashova
EVElena L. Vodovozova
Elena L. Vodovozova
Previously, a liposomal formulation of a chemotherapeutic agent melphalan (Mlph) incorporated in a fluid lipid bilayer of natural phospholipids in the form of dioleoylglyceride ester (MlphDG) was developed and the antitumor effect was confirmed in mouse models. The formulation composed of egg phosphatidylcholine (ePC), soybean phosphatidylinositol (PI), and MlphDG (8:1:1, by mol) showed stability in human serum for at least 4–5 h. On the contrary, replacing PI with pegylation of the liposomes, promoted fast dissociation of the components from the bilayer. In this work, interactions of MlphDG-liposomes with the most abundant plasma protein—albumin—in function of the presence of PI in the formulation were explored using Fourier transform infrared spectroscopy. The release of MlphDG from the liposomes was studied by asymmetrical flow field-flow fractionation (AF4) using micelles formed by a polyethylene glycol conjugate with phosphatidylethanolamine to mimic the physiological lipid sink like lipoproteins. Our results show that PI actually protects the membrane of MlphDG-liposomes from the protein penetration, presumably due to pairing between the positively charged MlphDG and negatively charged PI, which compensates for the heterogeneity of the lipid bilayer. The AF4 technique also evidences high stability of the formulation as a drug carrier.

20 July 2023 in Membranes
Verified
Journal Article
Open access
PDF file
DTDaria Tretiakova
Daria Tretiakova
MKMaria Kobanenko
Maria Kobanenko
AAAnna Alekseeva
Anna Alekseeva
IBIvan Boldyrev
Ivan Boldyrev
SKSergey Khaydukov
Sergey Khaydukov
NONatalia Onishchenko
Natalia Onishchenko
Despite the undisputable role of the protein corona in the biointeractions of liposome drug carriers, the field suffers from a lack of knowledge regarding the patterns of protein deposition on lipid surfaces with different compositions. Here, we investigated the protein coronas formed on liposomes of basic compositions containing combinations of egg phosphatidylcholine (PC), palmitoyloleoyl phosphatidylglycerol (POPG), and cholesterol. Liposome−protein complexes isolated by size-exclusion chromatography were delipidated and analyzed using label-free LC-MS/MS. The addition of the anionic lipid and cholesterol both affected the relative protein abundances (and not the total bound proteins) in the coronas. Highly anionic liposomes, namely those containing 40% POPG, carried corona enriched with cationic proteins (apolipoprotein C1, beta-2-glycoprotein 1, and cathelicidins) and were the least stable in the calcein release assay. Cholesterol improved the liposome stability in the plasma. However, the differences in the corona compositions had little effect on the liposome uptake by endothelial (EA.hy926) and phagocytic cells in the culture (U937) or ex vivo (blood-derived monocytes and neutrophils). The findings emphasize that the effect of protein corona on the performance of the liposomes as drug carriers occurs through compromising particle stability rather than interfering with cellular uptake.